114457-94-2,
(S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid,
(S)-3-Phenyl-2-[(pyrazin-2-ylcarbonyl)amino] propanoic acid,
N-Pyrazinylcarbonyl-L-phenylalanine,
N-(Pyrazinylcarbonyl)-L-phenylalanine,
(S)-3-Phenyl-2-[(pyrazine-2-carbonyl)-amino]-propionic acid,
L-Phenylalanine, N-(pyrazinylcarbonyl)-,
Q-102519,
(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoic acid,
(S)-3-Phenyl-2-[[(pyrazin-2-yl)carbonyl]amino]propanoic acid,
(pyrazine-2-carbonyl)-L-phenylalanine,
pyrazine-2-carbonylphenylalanine,
AK-55459,
L-Phenylalanine,N-(2-pyrazinylcarbonyl)-,
Bortezomib Impurity B,
L-Phenylalanine, N-(2-pyrazinylcarbonyl)-,
SCHEMBL535687,
N-pyrazineformyl-L-phenylalanine,
CTK4A8744,
KS-00000LOO,
DTXSID80567409,
DWYZPDHMMZGQAP-NSHDSACASA-N,
EBD12545,
AN-445,
ANW-45237,
MFCD09800536,
ZINC16698311,
AKOS010373022,
AC-9333,
CS-W020144,
RP29641,
N-(2-pyrazinylcarbonyl)-L-phenylalanine,
N-(Pyrazine-2-carbonyl)-L-phenylalanine,
AJ-69503,
AS-18728,
OR302741,
QC-10781,
N-(Pyrazine-2-ylcarbonyl)-L-phenylalanine,
AB0028920,
AX8048966,
DB-032318,
N-(pyrazine-2-yl-carbonyl)-L-phenylalanine,
ST2402819,
TC-133982,
FT-0674161,
P2068,
X1030,
3-Phenyl-2-[(pyrazine-2-carbonyl)amino]propionic Acid,
1093959-75-1,
C14H13N3O3,
ACN-034365,
(S)-3-phenyl-2-(pyrazine-2-carboxamido)propanoicacid,
(S)-3-phenyl-2-(pyrazine-2-carboxamido)propanoic acid, 95% - 1G 1g,